| Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins CJ Bloomquist, MB Mecham, MD Paradzinsky, R Janusziewicz, ... Journal of Controlled Release 278, 9-23, 2018 | 115 | 2018 |
| Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy JM Caster, KY Stephanie, AN Patel, NJ Newman, ZJ Lee, SB Warner, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (5), 1673-1683, 2017 | 115 | 2017 |
| Organ-specific metastases obtained by culturing colorectal cancer cells on tissue-specific decellularized scaffolds X Tian, ME Werner, KC Roche, AD Hanson, HP Foote, SK Yu, SB Warner, ... Nature biomedical engineering 2 (6), 443-452, 2018 | 99 | 2018 |
| Combined hepatic resection and radio-frequency ablation for patients with colorectal cancer liver metastasis: a viable option for patients with a large number of tumors T Masuda, GA Margonis, N Andreatos, J Wang, S Warner, MB Mirza, ... Anticancer research 38 (11), 6353-6360, 2018 | 43 | 2018 |
| Preclinical evaluation of promitil, a radiation-responsive liposomal formulation of mitomycin c prodrug, in chemoradiotherapy X Tian, SB Warner, KT Wagner, JM Caster, T Zhang, P Ohana, ... International Journal of Radiation Oncology* Biology* Physics 96 (3), 547-555, 2016 | 31 | 2016 |
| Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties JW Hickey, AY Isser, FP Vicente, SB Warner, HQ Mao, JP Schneck Biomaterials 187, 105-116, 2018 | 26 | 2018 |
| 3D printed drug-loaded implantable devices for intraoperative treatment of cancer CT Hagan IV, C Bloomquist, S Warner, NM Knape, I Kim, H Foley, ... Journal of Controlled Release 344, 147-156, 2022 | 19 | 2022 |
| KRAS mutational status impacts pathologic response to pre-hepatectomy chemotherapy: a study from the International Genetic Consortium for Liver Metastases GA Margonis, N Amini, N Andreatos, K Sasaki, J McVey, MB Mirza, ... HPB 21 (11), 1527-1534, 2019 | 12 | 2019 |
| Androgen receptor drives polyamine synthesis creating a vulnerability for prostate cancer R Kumar, S Jonnatan, DE Sanin, V Vakkala, A Kadam, S Kumar, ... medRxiv, 2024.12. 12.24318845, 2024 | | 2024 |
